Earnings Volatility Drives NPS Pharmaceuticals and These Stocks in a New Direction

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.13 in the quarter versus EPS of $0.08 in the year-earlier quarter. Revenue Decreased 31.78% to $36.51 million from the year-earlier quarter.

NPS Pharmaceuticals, Inc. reported adjusted EPS loss of $0.13 per share. By that measure, the company missed the mean analyst estimate of $-0.07. It beat the average revenue estimate of $31.62 million.

NPSP 20130811

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business